{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["D'Orazio B"],"funding":["NCATS NIH HHS","AHRQ HHS"],"pagination":["45-60"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9930995"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["16(1)"],"pubmed_abstract":["<h4>Background</h4>Methicillin-resistant or methicillin-sensitive Staphylococcus aureus skin and soft tissue infections pose serious clinical and public health challenges. Few protocols exist for outpatient education, decolonization and decontamination.<h4>Objectives</h4>This trial implemented infection prevention protocols in homes via community health workers/Promotoras.<h4>Methods</h4>We engaged clinicians, patient stakeholders, clinical and laboratory researchers, New York-based federally qualified health centers and community hospital emergency departments. The Clinician and Patient Stakeholder Advisory Committee (CPSAC) convened in person and remotely for shared decision-making and trial oversight.<h4>Results</h4>The intervention trial consented participants with skin and soft tissue infections from Methicillin-resistant Staphylococcus aureus or methicillin-sensitive Staphylococcus aureus, completed home visits, obtained surveillance cultures from index patients and household members and sampled household environmental surfaces at baseline and three months.<h4>Lessons learned</h4>The retention of the CPSAC during the trial demonstrated high levels of engagement.<h4>Conclusions</h4>CPSAC was highly effective throughout design and execution by troubleshooting recruitment and home visit challenges."],"journal":["Progress in community health partnerships : research, education, and action"],"pubmed_title":["Stakeholder Engagement In a Comparative Effectiveness/Implementation Study to Prevent <i>Staphylococcus Aureus</i> Infection Recurrence: CA-MRSA Project (CAMP2)."],"pmcid":["PMC9930995"],"funding_grant_id":["UL1 TR000043","P30 HS021667","UL1 TR001866"],"pubmed_authors":["Coller BS","Khalida C","Holder T","Nguyen R","D'Orazio B","Millan K","Vasquez KS","Davis R","Johnson V","Evering TH","Hassen GW","Hammock R","Tobin JN","Gonzalez J","Kost RG","Parola C","Ramachandran J"],"additional_accession":[]},"is_claimable":false,"name":"Stakeholder Engagement In a Comparative Effectiveness/Implementation Study to Prevent <i>Staphylococcus Aureus</i> Infection Recurrence: CA-MRSA Project (CAMP2).","description":"<h4>Background</h4>Methicillin-resistant or methicillin-sensitive Staphylococcus aureus skin and soft tissue infections pose serious clinical and public health challenges. Few protocols exist for outpatient education, decolonization and decontamination.<h4>Objectives</h4>This trial implemented infection prevention protocols in homes via community health workers/Promotoras.<h4>Methods</h4>We engaged clinicians, patient stakeholders, clinical and laboratory researchers, New York-based federally qualified health centers and community hospital emergency departments. The Clinician and Patient Stakeholder Advisory Committee (CPSAC) convened in person and remotely for shared decision-making and trial oversight.<h4>Results</h4>The intervention trial consented participants with skin and soft tissue infections from Methicillin-resistant Staphylococcus aureus or methicillin-sensitive Staphylococcus aureus, completed home visits, obtained surveillance cultures from index patients and household members and sampled household environmental surfaces at baseline and three months.<h4>Lessons learned</h4>The retention of the CPSAC during the trial demonstrated high levels of engagement.<h4>Conclusions</h4>CPSAC was highly effective throughout design and execution by troubleshooting recruitment and home visit challenges.","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2026-05-28T17:45:54.613Z","creation":"2026-04-08T02:51:36.615Z"},"accession":"S-EPMC9930995","cross_references":{"pubmed":["35342110"],"doi":["10.1353/cpr.2022.0005"]}}